Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Thymosin beta 4 acetate

Base Information Edit
  • Chemical Name:Thymosin beta 4 acetate
  • CAS No.:77591-33-4
  • Molecular Formula:C212H350N56O78S
  • Molecular Weight:4963.50
  • Hs Code.:
  • DSSTox Substance ID:DTXSID70228259
  • NCI Thesaurus Code:C166566
  • Mol file:77591-33-4.mol
Thymosin beta 4 acetate

Synonyms:Thymosinb4 (ox);L-Serine,N-acetyl-L-seryl-L-a-aspartyl-L-lysyl-L-prolyl-L-a-aspartyl-L-methionyl-L-alanyl-L-a-glutamyl-L-isoleucyl-L-a-glutamyl-L-lysyl-L-phenylalanyl-L-a-aspartyl-L-lysyl-L-seryl-L-lysyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-a-glutamyl-L-threonyl-L-glutaminyl-L-a-glutamyl-L-lysyl-L-asparaginyl-L-prolyl-L-leucyl-L-prolyl-L-seryl-L-lysyl-L-a-glutamyl-L-threonyl-L-isoleucyl-L-a-glutamyl-L-glutaminyl-L-a-glutamyl-L-lysyl-L-glutaminyl-L-alanylglycyl-L-a-glutamyl-;Peptide Fx (humanblood platelet);Thymosin b4 (Gekko gekko liver);Thymosin b4 (human);Thymosin b4 (rat);Thymosin β4 Acetate;Thymosin b4 (cattle);

Suppliers and Price of Thymosin beta 4 acetate
Supply Marketing:Edit
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Usbiological
  • Thymosin, beta 4
  • 1mg
  • $ 531.00
  • Usbiological
  • Thymosin Beta 4
  • 200ul
  • $ 453.00
  • Usbiological
  • Thymosin, beta 4
  • 1mg
  • $ 375.00
  • Usbiological
  • Thymosin Beta 4
  • 10ug
  • $ 343.00
  • Usbiological
  • Thymosin Beta 4
  • 10ug
  • $ 333.00
  • Usbiological
  • Thymosin Beta 4
  • 10ug
  • $ 327.00
  • Usbiological
  • Thymosin Beta 4
  • 10ug
  • $ 327.00
  • Usbiological
  • Thymosin Beta 4
  • 10ug
  • $ 293.00
  • Crysdot
  • Thymosinbeta4acetate 97%
  • 5mg
  • $ 208.00
  • Crysdot
  • Thymosinbeta4acetate 97%
  • 10mg
  • $ 312.00
Total 172 raw suppliers
Chemical Property of Thymosin beta 4 acetate Edit
Chemical Property:
  • PSA:2245.98000 
  • LogP:-0.85210 
  • Storage Temp.:Keep in dark place,Inert atmosphere,Store in freezer, under -20°C 
  • XLogP3:-43.5
  • Hydrogen Bond Donor Count:72
  • Hydrogen Bond Acceptor Count:88
  • Rotatable Bond Count:180
  • Exact Mass:4962.4930265
  • Heavy Atom Count:347
  • Complexity:12200
Purity/Quality:

99% *data from raw suppliers

Thymosin, beta 4 *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)N2CCCC2C(=O)NC(CC(C)C)C(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)O)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)N)C(=O)NC(C)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CC(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C
  • Isomeric SMILES:CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)C
  • Recent EU Clinical Trials:A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Venous Stasis Ulcers
  • Description Thymosin β-4 is an endogenous pro-angiogenic, fibroblast-activating peptide that is involved in hormone regulation. Thymosin β-4 also exhibits immunomodulatory and cardioprotective activities. Thymosin β-4 improves would healing in cardiac issue and improves cardiac function in vivo. Thymosin β-4 binds G-actin filaments, preventing actin polymerization.
Post RFQ for Price